Scholarlink

Purpose <p>Cardiovascular diseases (CVD) are a leading cause of mortality in Iran and globally. This study aimed to provide more accurate estimates of associations between risk factors and CVD mortality by applying competing risk models within the Tehran Lipid and Glucose Study cohort.</p> Methods <p>In this prospective analysis, 7,529 individuals aged ≥ 30 years without prevalent CVD were followed for a median of 19.87 years. The primary outcome was CVD mortality (<i>n</i> = 311), with non-CVD death as the competing event (<i>n</i> = 592). Analyses were stratified by sex and age (&lt; 65 vs. ≥65 years). Cause-specific and Fine-Gray models estimated hazard ratios for diabetes, hypertension, hypercholesterolemia, smoking, and body mass index.</p> Results <p>Diabetes and hypertension were the strongest predictors of CVD mortality across most subgroups. In the Fine-Gray model, diabetes showed the greatest impact in women &lt; 65 years (HR: 4.83, <i>p</i> &lt; 0.001), while hypertension showed the strongest association in women ≥ 65 years (HR: 3.32, <i>p</i> &lt; 0.001). Hypercholesterolemia was associated with increased CVD mortality exclusively in women &lt; 65 years (HR: 1.79, <i>p</i> = 0.02). Body mass index showed no significant association.</p> Conclusion <p>Diabetes and hypertension are the predominant risk factors for CVD mortality in the presence of competing risks, with effect magnitudes varying by sex and age. Applying competing risk models is essential for accurate risk estimation and targeted prevention in populations with high competing mortality burden.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Application of competing risks models in cardiovascular mortality research: findings from the Tehran lipid and glucose study

  • 期刊论文

  • 发表日期：

    2026年7月21日

查看全文
  • Masoumeh Mahdi-Akhgar,
  • Ebrahim Hajizadeh,
  • Ahmadreza Baghestani,
  • Davood Khalili,
  • Hamid Reza Khalkhali

摘要

Purpose

Cardiovascular diseases (CVD) are a leading cause of mortality in Iran and globally. This study aimed to provide more accurate estimates of associations between risk factors and CVD mortality by applying competing risk models within the Tehran Lipid and Glucose Study cohort.

Methods

In this prospective analysis, 7,529 individuals aged ≥ 30 years without prevalent CVD were followed for a median of 19.87 years. The primary outcome was CVD mortality (n = 311), with non-CVD death as the competing event (n = 592). Analyses were stratified by sex and age (< 65 vs. ≥65 years). Cause-specific and Fine-Gray models estimated hazard ratios for diabetes, hypertension, hypercholesterolemia, smoking, and body mass index.

Results

Diabetes and hypertension were the strongest predictors of CVD mortality across most subgroups. In the Fine-Gray model, diabetes showed the greatest impact in women < 65 years (HR: 4.83, p < 0.001), while hypertension showed the strongest association in women ≥ 65 years (HR: 3.32, p < 0.001). Hypercholesterolemia was associated with increased CVD mortality exclusively in women < 65 years (HR: 1.79, p = 0.02). Body mass index showed no significant association.

Conclusion

Diabetes and hypertension are the predominant risk factors for CVD mortality in the presence of competing risks, with effect magnitudes varying by sex and age. Applying competing risk models is essential for accurate risk estimation and targeted prevention in populations with high competing mortality burden.